🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
During end-stage kidney disease, clinical guidelines suggest reducing eleva...
Status
Recruiting
Location
Royal Prince Alfred Hosptial
Start Date
2019-12-10
Trial ID
NCT03573089
Treatments Being Tested
RATIONALE: Giving chemotherapy, such as fludarabine and busulfan, before a ...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2005-10
Trial ID
NCT00448357
The purpose of this study is to determine whether treatment with sitaglipti...
Status
Completed
Location
Grady Health System
Start Date
2016-01
Trial ID
NCT02556918
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2001-02
Trial ID
NCT00004188
Treatments Being Tested
The prevalence of chronic kidney disease (CKD) in the adult population is e...
Status
Recruiting
Location
Department of Nephrology, outpatient clinic, Herlev Hospital
Start Date
2025-11-20
Trial ID
NCT07171216
Treatments Being Tested
Patients with end-stage renal disease (ESRD) who have elevated serum phosph...
Status
Completed
Location
Foothills Medical Centre
Start Date
2014-01
Trial ID
NCT01994733
The purpose of this study is to compare sitagliptin and placebo for the pre...
Status
Completed
Location
Grady Health System
Start Date
2016-01
Trial ID
NCT02443402